ZA841597B - Human nerve growth factor by recombinant technology - Google Patents
Human nerve growth factor by recombinant technologyInfo
- Publication number
- ZA841597B ZA841597B ZA841597A ZA841597A ZA841597B ZA 841597 B ZA841597 B ZA 841597B ZA 841597 A ZA841597 A ZA 841597A ZA 841597 A ZA841597 A ZA 841597A ZA 841597 B ZA841597 B ZA 841597B
- Authority
- ZA
- South Africa
- Prior art keywords
- growth factor
- nerve growth
- human nerve
- recombinant technology
- human
- Prior art date
Links
- 102000015336 Nerve Growth Factor Human genes 0.000 title abstract 2
- 108010025020 Nerve Growth Factor Proteins 0.000 title abstract 2
- 229940053128 nerve growth factor Drugs 0.000 title abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47196283A | 1983-03-03 | 1983-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA841597B true ZA841597B (en) | 1984-10-31 |
Family
ID=23873671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA841597A ZA841597B (en) | 1983-03-03 | 1984-03-02 | Human nerve growth factor by recombinant technology |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0121338B2 (de) |
| JP (4) | JPS6084299A (de) |
| KR (1) | KR840008026A (de) |
| AT (1) | ATE45382T1 (de) |
| AU (1) | AU574350B2 (de) |
| CA (1) | CA1220736A (de) |
| DE (1) | DE3479321D1 (de) |
| DK (1) | DK161152C (de) |
| ES (1) | ES530202A0 (de) |
| IE (1) | IE57013B1 (de) |
| NZ (1) | NZ207337A (de) |
| ZA (1) | ZA841597B (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE105868T1 (de) * | 1985-09-12 | 1994-06-15 | Scios Nova Inc | Rekombinanter fibroblast-wachstumsfaktor. |
| JPH01102096A (ja) * | 1987-10-15 | 1989-04-19 | Sanwa Kagaku Kenkyusho Co Ltd | モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法 |
| JPH01211490A (ja) * | 1988-02-19 | 1989-08-24 | Tosoh Corp | ヒト神経成長因子遺伝子セグメント |
| IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
| US5134121A (en) * | 1988-03-28 | 1992-07-28 | Regents Of The University Of California | Nerve growth factor peptides |
| US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
| JPH0771509B2 (ja) * | 1988-07-12 | 1995-08-02 | 工業技術院長 | ヒトβ−NGFの発現法 |
| US5082774A (en) * | 1988-08-30 | 1992-01-21 | The General Hospital Corporation | Recombinant human nerve growth factor |
| US5272063A (en) * | 1988-11-22 | 1993-12-21 | Syntex (U.S.A.) Inc. | Process of making human nerve growth factor |
| US6709837B1 (en) | 1989-03-10 | 2004-03-23 | Takeda Chemical Industries, Inc. | Polypeptide and production thereof |
| SE8901715L (sv) * | 1989-05-12 | 1990-11-13 | Lope Medicine Ab | En plasmid dna-konstruktion innehaallande dna-sekvenser |
| IT1232157B (it) * | 1989-07-20 | 1992-01-25 | Fidia Farmaceutici | Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita' |
| DE69017793T2 (de) * | 1989-08-21 | 1995-08-24 | Takeda Chemical Industries Ltd | Produktion von menschlichen Nervenwachstumsfaktoren. |
| US5656435A (en) * | 1989-08-28 | 1997-08-12 | Takeda Chemical Industries, Ltd. | Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof |
| US6933276B1 (en) | 1989-08-30 | 2005-08-23 | Regeneron Pharmaceuticals, Inc. | Methods of treating peripheral neuropathies using neurotrophin-3 |
| IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
| US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
| IT1238348B (it) * | 1989-11-16 | 1993-07-13 | Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote. | |
| JPH03244385A (ja) * | 1990-02-21 | 1991-10-31 | Hitachi Ltd | ヒト神経成長因子の遺伝子工学的生産方法 |
| IT1239271B (it) * | 1990-02-27 | 1993-10-01 | Fidia Spa | Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante |
| US5606031A (en) * | 1990-04-06 | 1997-02-25 | Lile; Jack | Production and purification of biologically active recombinant neurotrophic protein in bacteria |
| US5986070A (en) * | 1990-04-06 | 1999-11-16 | Amgen Inc. | Production of biologically active NGF proteins |
| US5235043A (en) * | 1990-04-06 | 1993-08-10 | Synergen, Inc. | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
| PT100580A (pt) * | 1991-06-12 | 1993-09-30 | Regeneron Pharma | Producao e recuperacao de neurotrofinas recombinantes |
| DE4139000A1 (de) * | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
| US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
| US6566094B1 (en) * | 1996-09-11 | 2003-05-20 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin gene: Semaphorin Y |
| ES2293662T3 (es) | 1996-11-15 | 2008-03-16 | Genentech, Inc. | Purificacion de neurotrofinas. |
| EP0977778A2 (de) * | 1997-02-06 | 2000-02-09 | Hoechst Marion Roussel, Inc. | Promotoren von exon 1 und exon 3 des menschlichen nervenwachstumsfaktors. |
| US6197551B1 (en) * | 1998-01-27 | 2001-03-06 | Millennium Pharmaceuticals, Inc. | Spoil-1 protein and nucleic acid molecules and uses therefor |
| ITRM20050045A1 (it) * | 2005-02-02 | 2006-08-03 | Consiglio Nazionale Ricerche | Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi. |
| US7294384B2 (en) | 2005-09-27 | 2007-11-13 | Milliken & Company | Moldable construction incorporating bonding interface |
| US7378359B2 (en) | 2005-09-27 | 2008-05-27 | Eleazer Howell B | Moldable fibrous construction incorporating non-woven layers |
| US7300691B2 (en) | 2005-09-27 | 2007-11-27 | Milliken & Company | Moldable construction incorporating non-olefin bonding interface |
| US20080124513A1 (en) | 2006-09-11 | 2008-05-29 | Eleazer Howell B | Moldable fabric with unidirectional tape yarns |
| JP6767688B2 (ja) | 2015-05-20 | 2020-10-14 | パナソニックIpマネジメント株式会社 | 室内空調システム |
| IT202000005542A1 (it) | 2020-03-16 | 2021-09-16 | Themis S R L | Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185095A (en) * | 1977-11-23 | 1980-01-22 | The Massachusetts General Hospital | Nerve growth factor |
| ZA811368B (en) † | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
-
1984
- 1984-02-24 DK DK098884A patent/DK161152C/da not_active IP Right Cessation
- 1984-03-01 ES ES530202A patent/ES530202A0/es active Granted
- 1984-03-01 IE IE493/84A patent/IE57013B1/en not_active IP Right Cessation
- 1984-03-01 NZ NZ207337A patent/NZ207337A/en unknown
- 1984-03-02 KR KR1019840001051A patent/KR840008026A/ko not_active Ceased
- 1984-03-02 EP EP84301377A patent/EP0121338B2/de not_active Expired - Lifetime
- 1984-03-02 ZA ZA841597A patent/ZA841597B/xx unknown
- 1984-03-02 AU AU25252/84A patent/AU574350B2/en not_active Expired
- 1984-03-02 JP JP59041205A patent/JPS6084299A/ja active Granted
- 1984-03-02 AT AT84301377T patent/ATE45382T1/de not_active IP Right Cessation
- 1984-03-02 CA CA000448766A patent/CA1220736A/en not_active Expired
- 1984-03-02 DE DE8484301377T patent/DE3479321D1/de not_active Expired
-
1992
- 1992-07-13 JP JP4185044A patent/JP2740417B2/ja not_active Expired - Lifetime
- 1992-12-25 JP JP4346109A patent/JPH067169A/ja active Pending
- 1992-12-25 JP JP4346116A patent/JP2898494B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2525284A (en) | 1984-09-06 |
| ES8600783A1 (es) | 1985-11-01 |
| JPH067169A (ja) | 1994-01-18 |
| JP2898494B2 (ja) | 1999-06-02 |
| CA1220736A (en) | 1987-04-21 |
| ES530202A0 (es) | 1985-11-01 |
| ATE45382T1 (de) | 1989-08-15 |
| NZ207337A (en) | 1987-11-27 |
| EP0121338B1 (de) | 1989-08-09 |
| JPH0536031B2 (de) | 1993-05-28 |
| EP0121338A1 (de) | 1984-10-10 |
| JPS6084299A (ja) | 1985-05-13 |
| AU574350B2 (en) | 1988-07-07 |
| EP0121338B2 (de) | 1999-10-27 |
| IE840493L (en) | 1984-09-03 |
| DK98884D0 (da) | 1984-02-24 |
| DE3479321D1 (en) | 1989-09-14 |
| JPH0690764A (ja) | 1994-04-05 |
| KR840008026A (ko) | 1984-12-12 |
| DK161152B (da) | 1991-06-03 |
| DK98884A (da) | 1984-10-04 |
| JP2740417B2 (ja) | 1998-04-15 |
| IE57013B1 (en) | 1992-03-11 |
| DK161152C (da) | 1991-11-11 |
| JPH05310792A (ja) | 1993-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA841597B (en) | Human nerve growth factor by recombinant technology | |
| GR78180B (de) | ||
| GB8721424D0 (en) | Recombinant expression method | |
| GB8705117D0 (en) | Modulating bias control | |
| ZA868689B (en) | Modified fibrinolytic agents | |
| AU538804B2 (en) | Control of atmosphere surrounding crystal growth zone | |
| HUT43111A (en) | Process for producing human lizozime | |
| IN164247B (de) | ||
| GB8509915D0 (en) | Regulating concentration of carbonate | |
| GB8622568D0 (en) | Control of atmosphere | |
| GB2153700B (en) | Crystal growth | |
| PL268344A1 (en) | The method of manufacture of fuel from carbon | |
| GR862928B (en) | Composition regulating the plants growth | |
| IL81751A0 (en) | Fermentation of bacteria at high productivities | |
| GB8526027D0 (en) | Tissue culture | |
| GB2195641B (en) | Polypeptide with interleukin-2 activity | |
| JPS5791123A (en) | Cultivation of "maetake" (mushroom) | |
| GR851016B (de) | ||
| SU1208765A1 (ru) | Способ получения производных феноксифенилмочевины | |
| SU1167881A1 (ru) | Фенилгидразид морфолинодиэтилуксусной кислоты, обладающий противотуберкулезным действием | |
| SU1147747A1 (en) | Method of growing yeast | |
| CS767086A1 (en) | Connection of controlled amplifier controlled by two control voltages | |
| PL245909A1 (en) | Controlled current source | |
| BG42195A1 (en) | Growth regulator of cotton | |
| ZA848818B (en) | Cultivation of micro-organisms |